NICOLE HENDRICKSON: Open Payments
NPI 1881242725 · SPRING GROVE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,979 in 104 payments from 15 companies in 2025. Trend: 2023 $686 · 2024 $1,559 · 2025 $1,979
Food & beverage: $1,979
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $484 |
| Tris Pharma Inc | 17 | $389 |
| Neurocrine BioSciences, Inc. | 6 | $264 |
| Corium, LLC | 10 | $170 |
| Axsome Therapeutics, Inc. | 13 | $147 |
| Neos Therapeutics, LP | 9 | $145 |
| Otsuka America Pharmaceutical, Inc. | 5 | $121 |
| Alkermes, Inc. | 5 | $94 |
| Lundbeck LLC | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
Products named: VRAYLAR, Dyanavel XR, INGREZZA, Azstarys, REXULTI, Auvelity, Adzenys XR-ODT, ARISTADA.
Industry payments across IL — which companies pay providers there.
